| 0 |
AICHMOPHOBIA |
1 |
0.5000 |
| 1 |
CHOLANGIOSARCOMA |
3 |
0.3750 |
| 2 |
HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
6 |
0.2857 |
| 3 |
OVARIAN HYPERSTIMULATION SYNDROME |
640 |
0.2743 |
| 4 |
HYPOTHALAMIC ENLARGEMENT |
1 |
0.2500 |
| 5 |
LUTEINISING UNRUPTURED FOLLICLE SYNDROME |
1 |
0.2000 |
| 6 |
POOR RESPONSE TO OVULATION INDUCTION |
2 |
0.1818 |
| 7 |
SEX CHROMOSOME ABNORMALITY |
3 |
0.1429 |
| 8 |
PROTEIN S ABNORMAL |
2 |
0.1429 |
| 9 |
ARTIFICIAL INSEMINATION |
1 |
0.1429 |
| 10 |
CRI DU CHAT SYNDROME |
1 |
0.1250 |
| 11 |
KAYSER-FLEISCHER RING |
1 |
0.1250 |
| 12 |
DECREASED EMBRYO VIABILITY |
3 |
0.1250 |
| 13 |
TRISOMY 22 |
2 |
0.1176 |
| 14 |
OVARIAN HAEMORRHAGE |
25 |
0.1055 |
| 15 |
FAILED IN VITRO FERTILISATION |
5 |
0.0820 |
| 16 |
HYPOPITUITARISM FOETAL |
1 |
0.0769 |
| 17 |
MULTIPLE PREGNANCY |
12 |
0.0670 |
| 18 |
VAGINAL CUFF DEHISCENCE |
2 |
0.0667 |
| 19 |
HETEROTOPIC PREGNANCY |
4 |
0.0635 |
| 20 |
OVARIAN ENLARGEMENT |
23 |
0.0601 |
| 21 |
DIMINISHED OVARIAN RESERVE |
1 |
0.0526 |
| 22 |
ENCEPHALITIS POST VARICELLA |
1 |
0.0526 |
| 23 |
DRUG DISPENSING ISSUE |
1 |
0.0526 |
| 24 |
PREMATURE OVULATION |
4 |
0.0513 |
| 25 |
TUBEROUS SCLEROSIS |
2 |
0.0465 |
| 26 |
CORRECTED TRANSPOSITION OF GREAT VESSELS |
1 |
0.0455 |
| 27 |
HUMAN CHORIONIC GONADOTROPIN DECREASED |
5 |
0.0450 |
| 28 |
VANISHING TWIN SYNDROME |
4 |
0.0449 |
| 29 |
FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE |
3 |
0.0435 |
| 30 |
ENDOMETRIAL HYPOPLASIA |
1 |
0.0417 |
| 31 |
PREGNANCY TEST NEGATIVE |
4 |
0.0381 |
| 32 |
ADNEXAL TORSION |
12 |
0.0379 |
| 33 |
RHABDOMYOMA |
2 |
0.0377 |
| 34 |
BIOCHEMICAL PREGNANCY |
4 |
0.0370 |
| 35 |
PROGESTERONE INCREASED |
4 |
0.0360 |
| 36 |
HUMAN CHORIONIC GONADOTROPIN POSITIVE |
2 |
0.0351 |
| 37 |
HUMAN CHORIONIC GONADOTROPIN ABNORMAL |
2 |
0.0345 |
| 38 |
CAPUT SUCCEDANEUM |
1 |
0.0345 |
| 39 |
OVARIAN RUPTURE |
4 |
0.0342 |
| 40 |
ANOVULATORY CYCLE |
7 |
0.0338 |
| 41 |
OVARIAN ABSCESS |
5 |
0.0321 |
| 42 |
NONINFECTIVE OOPHORITIS |
2 |
0.0299 |
| 43 |
ADRENAL INSUFFICIENCY NEONATAL |
1 |
0.0294 |
| 44 |
TUBO-OVARIAN ABSCESS |
7 |
0.0287 |
| 45 |
BLOOD OESTROGEN INCREASED |
16 |
0.0272 |
| 46 |
PELVIC FLUID COLLECTION |
19 |
0.0270 |
| 47 |
OVARIAN TORSION |
2 |
0.0241 |
| 48 |
HETEROTAXIA |
4 |
0.0240 |
| 49 |
HAEMOCONCENTRATION |
4 |
0.0231 |
| 50 |
BASILAR ARTERY THROMBOSIS |
4 |
0.0222 |
| 51 |
HYDROSALPINX |
2 |
0.0217 |
| 52 |
OOPHORITIS |
3 |
0.0211 |
| 53 |
CEPHALO-PELVIC DISPROPORTION |
4 |
0.0200 |
| 54 |
KIDNEY ANGIOMYOLIPOMA |
1 |
0.0200 |
| 55 |
VERTEBRAL ARTERY DISSECTION |
4 |
0.0196 |
| 56 |
TWIN PREGNANCY |
16 |
0.0190 |
| 57 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
17 |
0.0190 |
| 58 |
ADNEXA UTERI CYST |
3 |
0.0185 |
| 59 |
AUTOSOMAL CHROMOSOME ANOMALY |
1 |
0.0185 |
| 60 |
BENIGN HYDATIDIFORM MOLE |
6 |
0.0181 |
| 61 |
HYPOOSMOLAR STATE |
2 |
0.0163 |
| 62 |
MELANODERMA |
3 |
0.0156 |
| 63 |
LEUKOPENIA NEONATAL |
1 |
0.0152 |
| 64 |
BORDERLINE OVARIAN TUMOUR |
1 |
0.0149 |
| 65 |
DRUG EXPOSURE BEFORE PREGNANCY |
15 |
0.0148 |
| 66 |
BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED |
3 |
0.0141 |
| 67 |
BLADDER TAMPONADE |
4 |
0.0132 |
| 68 |
SECONDARY HYPOTHYROIDISM |
2 |
0.0131 |
| 69 |
PELVIC HAEMATOMA |
5 |
0.0113 |
| 70 |
MYCOBACTERIUM FORTUITUM INFECTION |
2 |
0.0108 |
| 71 |
ECTOPIC PREGNANCY |
33 |
0.0107 |
| 72 |
BLOOD VISCOSITY ABNORMAL |
1 |
0.0105 |
| 73 |
CLINICALLY ISOLATED SYNDROME |
1 |
0.0105 |
| 74 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
71 |
0.0104 |
| 75 |
ABORTION SPONTANEOUS INCOMPLETE |
1 |
0.0103 |
| 76 |
ABORTION THREATENED |
5 |
0.0100 |
| 77 |
PRODUCT ADMINISTRATION ISSUE |
2 |
0.0096 |
| 78 |
OVULATION PAIN |
2 |
0.0095 |
| 79 |
CEPHALHAEMATOMA |
1 |
0.0090 |
| 80 |
ABDOMINAL REBOUND TENDERNESS |
1 |
0.0089 |
| 81 |
INSULIN-LIKE GROWTH FACTOR ABNORMAL |
1 |
0.0088 |
| 82 |
CYST RUPTURE |
6 |
0.0088 |
| 83 |
BREAST DISORDER MALE |
1 |
0.0086 |
| 84 |
OVARIAN CYST RUPTURED |
11 |
0.0086 |
| 85 |
FONTANELLE BULGING |
1 |
0.0085 |
| 86 |
CEREBROSPINAL FLUID RETENTION |
1 |
0.0085 |
| 87 |
DYSPLASTIC NAEVUS |
3 |
0.0083 |
| 88 |
HEPATO-LENTICULAR DEGENERATION |
1 |
0.0079 |
| 89 |
OVARIAN FAILURE |
4 |
0.0075 |
| 90 |
OVARIAN DISORDER |
7 |
0.0074 |
| 91 |
BONE FISSURE |
3 |
0.0072 |
| 92 |
COR PULMONALE ACUTE |
2 |
0.0071 |
| 93 |
DELAYED DELIVERY |
1 |
0.0070 |
| 94 |
HAEMORRHAGIC ASCITES |
2 |
0.0070 |
| 95 |
HAEMORRHAGIC OVARIAN CYST |
4 |
0.0070 |
| 96 |
ENDOMETRIAL ATROPHY |
1 |
0.0069 |
| 97 |
ACUTE ABDOMEN |
10 |
0.0068 |
| 98 |
OESTRADIOL INCREASED |
2 |
0.0066 |
| 99 |
LIPOSUCTION |
1 |
0.0065 |
| 100 |
RUPTURED ECTOPIC PREGNANCY |
5 |
0.0065 |
| 101 |
POLYCYSTIC OVARIES |
10 |
0.0064 |
| 102 |
PROGESTERONE DECREASED |
2 |
0.0064 |
| 103 |
FOETAL GROWTH ABNORMALITY |
1 |
0.0064 |
| 104 |
AMNIOCENTESIS ABNORMAL |
1 |
0.0064 |
| 105 |
BLADDER INJURY |
2 |
0.0063 |
| 106 |
OESTRADIOL DECREASED |
2 |
0.0062 |
| 107 |
ANAPLASTIC ASTROCYTOMA |
1 |
0.0061 |
| 108 |
TESTICULAR DISORDER |
6 |
0.0060 |
| 109 |
CEREBELLAR HYPOPLASIA |
1 |
0.0060 |
| 110 |
SUPRAPUBIC PAIN |
3 |
0.0059 |
| 111 |
FOETAL CHROMOSOME ABNORMALITY |
1 |
0.0059 |
| 112 |
ANAEMIA OF PREGNANCY |
1 |
0.0058 |
| 113 |
TESTICULAR ATROPHY |
5 |
0.0057 |
| 114 |
ANDROGEN DEFICIENCY |
2 |
0.0057 |
| 115 |
MENTAL RETARDATION |
2 |
0.0057 |
| 116 |
PUNCTURE SITE HAEMORRHAGE |
4 |
0.0056 |
| 117 |
BLOOD LUTEINISING HORMONE DECREASED |
1 |
0.0056 |
| 118 |
POOR QUALITY PRODUCT ADMINISTERED |
58 |
0.0055 |
| 119 |
ADNEXA UTERI PAIN |
7 |
0.0055 |
| 120 |
HYDROMETRA |
1 |
0.0054 |
| 121 |
LID SULCUS DEEPENED |
2 |
0.0054 |
| 122 |
HEPATIC VASCULAR THROMBOSIS |
1 |
0.0052 |
| 123 |
INJECTION SITE ECZEMA |
1 |
0.0052 |
| 124 |
CONGENITAL PULMONARY HYPERTENSION |
1 |
0.0052 |
| 125 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
2 |
0.0051 |
| 126 |
PREGNANCY TEST POSITIVE |
2 |
0.0051 |
| 127 |
HAEMOPERITONEUM |
4 |
0.0050 |
| 128 |
MANUFACTURING MATERIALS ISSUE |
2 |
0.0050 |
| 129 |
ABORTION MISSED |
6 |
0.0047 |
| 130 |
CHORIORETINITIS |
3 |
0.0047 |
| 131 |
JUGULAR VEIN THROMBOSIS |
8 |
0.0045 |
| 132 |
CONGENITAL PULMONARY VALVE ATRESIA |
1 |
0.0045 |
| 133 |
FAT REDISTRIBUTION |
1 |
0.0043 |
| 134 |
PREGNANCY TEST FALSE POSITIVE |
2 |
0.0043 |
| 135 |
INJECTION SITE GRANULOMA |
1 |
0.0042 |
| 136 |
INTRA-ABDOMINAL HAEMORRHAGE |
10 |
0.0042 |
| 137 |
FOREIGN BODY REACTION |
1 |
0.0041 |
| 138 |
ENCEPHALOCELE |
1 |
0.0040 |
| 139 |
CEREBRAL ARTERY THROMBOSIS |
2 |
0.0039 |
| 140 |
EPILEPTIC AURA |
1 |
0.0039 |
| 141 |
CONGENITAL HYPOTHYROIDISM |
1 |
0.0039 |
| 142 |
INTRA-UTERINE DEATH |
6 |
0.0037 |
| 143 |
CLINODACTYLY |
1 |
0.0036 |
| 144 |
GENITOURINARY TRACT INFECTION |
1 |
0.0035 |
| 145 |
ADNEXA UTERI MASS |
1 |
0.0035 |
| 146 |
FALLOPIAN TUBE DISORDER |
1 |
0.0034 |
| 147 |
EAR TUBE INSERTION |
1 |
0.0034 |
| 148 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
1 |
0.0034 |
| 149 |
CONGENITAL CHOROID PLEXUS CYST |
1 |
0.0033 |
| 150 |
HYPNAGOGIC HALLUCINATION |
1 |
0.0033 |
| 151 |
PELVIC DISCOMFORT |
3 |
0.0032 |
| 152 |
FOETAL CARDIAC DISORDER |
1 |
0.0032 |
| 153 |
ASCITES |
92 |
0.0031 |
| 154 |
MENSTRUATION NORMAL |
1 |
0.0030 |
| 155 |
ALLERGIC RESPIRATORY SYMPTOM |
1 |
0.0030 |
| 156 |
LUNG PERFORATION |
1 |
0.0030 |
| 157 |
WAIST CIRCUMFERENCE INCREASED |
3 |
0.0029 |
| 158 |
JOINT ABSCESS |
1 |
0.0029 |
| 159 |
OVERLAP SYNDROME |
2 |
0.0029 |
| 160 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
1 |
0.0028 |
| 161 |
KIDNEY MALFORMATION |
1 |
0.0028 |
| 162 |
INTRA-ABDOMINAL FLUID COLLECTION |
5 |
0.0028 |
| 163 |
AMNIOTIC CAVITY INFECTION |
2 |
0.0028 |
| 164 |
CEREBRAL VENOUS THROMBOSIS |
5 |
0.0028 |
| 165 |
OVARIAN MASS |
2 |
0.0027 |
| 166 |
LOCAL REACTION |
2 |
0.0027 |
| 167 |
INFERTILITY |
4 |
0.0027 |
| 168 |
COMPLICATION OF PREGNANCY |
2 |
0.0026 |
| 169 |
AZOOSPERMIA |
1 |
0.0026 |
| 170 |
HYPEREMESIS GRAVIDARUM |
1 |
0.0026 |
| 171 |
BLIGHTED OVUM |
1 |
0.0025 |
| 172 |
ENDOMETRIAL HYPERTROPHY |
1 |
0.0025 |
| 173 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
2 |
0.0025 |
| 174 |
PRODUCT CONTAINER ISSUE |
21 |
0.0024 |
| 175 |
LOW SET EARS |
1 |
0.0024 |
| 176 |
HYDROTHORAX |
2 |
0.0024 |
| 177 |
MELANOMA RECURRENT |
1 |
0.0024 |
| 178 |
SUPERFICIAL VEIN THROMBOSIS |
2 |
0.0024 |
| 179 |
PRODUCT CONTAMINATION PHYSICAL |
6 |
0.0024 |
| 180 |
PATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0023 |
| 181 |
PRODUCT LEAKAGE |
13 |
0.0023 |
| 182 |
INFERTILITY MALE |
1 |
0.0022 |
| 183 |
BONE INFARCTION |
1 |
0.0022 |
| 184 |
FOETAL HEART RATE ABNORMAL |
2 |
0.0022 |
| 185 |
ATRIOVENTRICULAR SEPTAL DEFECT |
1 |
0.0021 |
| 186 |
THERAPEUTIC RESPONSE INCREASED |
2 |
0.0021 |
| 187 |
MASTOCYTOSIS |
1 |
0.0021 |
| 188 |
PLACENTAL DISORDER |
2 |
0.0021 |
| 189 |
OVARIAN CYST |
21 |
0.0021 |
| 190 |
HYPERCOAGULATION |
4 |
0.0021 |
| 191 |
PREMATURE RUPTURE OF MEMBRANES |
5 |
0.0021 |
| 192 |
TENSION |
12 |
0.0020 |
| 193 |
CERVICAL INCOMPETENCE |
1 |
0.0020 |
| 194 |
HYPERLIPASAEMIA |
1 |
0.0019 |
| 195 |
ANAL ATRESIA |
1 |
0.0019 |
| 196 |
ABORTION SPONTANEOUS |
75 |
0.0019 |
| 197 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 198 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
2 |
0.0018 |
| 199 |
MANUFACTURING PRODUCT SHIPPING ISSUE |
1 |
0.0018 |
| 200 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 201 |
BLOOD TESTOSTERONE ABNORMAL |
2 |
0.0018 |
| 202 |
EPSTEIN-BARR VIRAEMIA |
2 |
0.0018 |
| 203 |
CYTOGENETIC ABNORMALITY |
2 |
0.0018 |
| 204 |
ANENCEPHALY |
1 |
0.0018 |
| 205 |
SUBCLAVIAN VEIN THROMBOSIS |
2 |
0.0018 |
| 206 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
1 |
0.0017 |
| 207 |
PRODUCT PREPARATION ISSUE |
11 |
0.0017 |
| 208 |
LOW BIRTH WEIGHT BABY |
13 |
0.0016 |
| 209 |
HYDROPS FOETALIS |
1 |
0.0016 |
| 210 |
XEROSIS |
2 |
0.0016 |
| 211 |
ADENOCARCINOMA OF COLON |
3 |
0.0016 |
| 212 |
VAGINAL ODOUR |
2 |
0.0016 |
| 213 |
ABDOMINAL PAIN LOWER |
40 |
0.0016 |
| 214 |
HYPOPROTEINAEMIA |
3 |
0.0016 |
| 215 |
ENDOMETRIAL ADENOCARCINOMA |
1 |
0.0016 |
| 216 |
DRUG LEVEL DECREASED |
16 |
0.0016 |
| 217 |
EXTREMITY CONTRACTURE |
1 |
0.0016 |
| 218 |
PRODUCT AVAILABILITY ISSUE |
35 |
0.0015 |
| 219 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 220 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
50 |
0.0015 |
| 221 |
INFECTIOUS PERITONITIS |
1 |
0.0015 |
| 222 |
COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS |
1 |
0.0015 |
| 223 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
25 |
0.0015 |
| 224 |
PERITONEAL HAEMORRHAGE |
2 |
0.0014 |
| 225 |
LEIOMYOMA |
1 |
0.0014 |
| 226 |
CHRONIC FATIGUE SYNDROME |
2 |
0.0014 |
| 227 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 228 |
GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 229 |
PELVIC VENOUS THROMBOSIS |
2 |
0.0014 |
| 230 |
HAEMORRHAGE IN PREGNANCY |
2 |
0.0014 |
| 231 |
LARYNGEAL DISORDER |
1 |
0.0014 |
| 232 |
ABORTION INDUCED |
13 |
0.0014 |
| 233 |
HYPOTHALAMO-PITUITARY DISORDER |
2 |
0.0014 |
| 234 |
LIQUID PRODUCT PHYSICAL ISSUE |
10 |
0.0014 |
| 235 |
THYROIDITIS |
4 |
0.0013 |
| 236 |
BLOOD LOSS ANAEMIA |
3 |
0.0013 |
| 237 |
PRODUCT STORAGE ISSUE |
5 |
0.0013 |
| 238 |
INFERTILITY FEMALE |
2 |
0.0013 |
| 239 |
INJECTION SITE HYPERSENSITIVITY |
4 |
0.0013 |
| 240 |
METAPNEUMOVIRUS INFECTION |
1 |
0.0013 |
| 241 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 242 |
AORTIC DISORDER |
1 |
0.0013 |
| 243 |
TESTICULAR PAIN |
4 |
0.0013 |
| 244 |
NO ADVERSE EVENT |
227 |
0.0013 |
| 245 |
HEPATITIS VIRAL |
1 |
0.0012 |
| 246 |
DIABETES INSIPIDUS |
3 |
0.0012 |
| 247 |
BREAST OPERATION |
1 |
0.0012 |
| 248 |
PELVIC PAIN |
22 |
0.0012 |
| 249 |
SMALL FOR DATES BABY |
6 |
0.0012 |
| 250 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 251 |
CULTURE POSITIVE |
1 |
0.0012 |
| 252 |
AMAUROSIS |
1 |
0.0012 |
| 253 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
83 |
0.0012 |
| 254 |
CHOROIDAL NEOVASCULARISATION |
1 |
0.0012 |
| 255 |
CORONARY ARTERY DISSECTION |
1 |
0.0012 |
| 256 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 257 |
PRODUCT CONTAINER SEAL ISSUE |
2 |
0.0011 |
| 258 |
AXIAL SPONDYLOARTHRITIS |
1 |
0.0011 |
| 259 |
LARGE FOR DATES BABY |
1 |
0.0011 |
| 260 |
PRODUCT DOSE OMISSION |
74 |
0.0011 |
| 261 |
BREAST SWELLING |
3 |
0.0011 |
| 262 |
UTERINE POLYP |
2 |
0.0011 |
| 263 |
IMPLANT SITE PRURITUS |
1 |
0.0011 |
| 264 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 265 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 266 |
ABDOMINAL DISTENSION |
113 |
0.0011 |
| 267 |
MENINGIOMA BENIGN |
1 |
0.0011 |
| 268 |
PREMATURE LABOUR |
6 |
0.0011 |
| 269 |
LIPOATROPHY |
1 |
0.0011 |
| 270 |
RETINAL VEIN OCCLUSION |
3 |
0.0010 |
| 271 |
CAESAREAN SECTION |
12 |
0.0010 |
| 272 |
ABORTION |
3 |
0.0010 |
| 273 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
2 |
0.0010 |
| 274 |
HORMONE LEVEL ABNORMAL |
5 |
0.0010 |
| 275 |
BLOOD TESTOSTERONE DECREASED |
7 |
0.0010 |
| 276 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 277 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 278 |
DUST ALLERGY |
1 |
0.0010 |
| 279 |
VENOUS THROMBOSIS |
4 |
0.0010 |
| 280 |
HEMIANOPIA |
1 |
0.0010 |
| 281 |
MESENTERIC VEIN THROMBOSIS |
1 |
0.0010 |
| 282 |
LIBIDO INCREASED |
2 |
0.0010 |
| 283 |
NIPPLE PAIN |
2 |
0.0010 |
| 284 |
PRODUCT SUPPLY ISSUE |
7 |
0.0010 |
| 285 |
VENOUS THROMBOSIS LIMB |
2 |
0.0010 |
| 286 |
GENERALISED TONIC-CLONIC SEIZURE |
16 |
0.0010 |
| 287 |
OLIGURIA |
6 |
0.0010 |
| 288 |
FEEDING DISORDER NEONATAL |
1 |
0.0010 |
| 289 |
LIVE BIRTH |
8 |
0.0010 |
| 290 |
HYDROCELE |
1 |
0.0009 |
| 291 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 292 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 293 |
FOETAL MALFORMATION |
1 |
0.0009 |
| 294 |
MATERNAL DRUGS AFFECTING FOETUS |
7 |
0.0009 |
| 295 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
5 |
0.0009 |
| 296 |
OLIGOHYDRAMNIOS |
3 |
0.0009 |
| 297 |
CLEFT LIP AND PALATE |
1 |
0.0009 |
| 298 |
DRUG EFFECT VARIABLE |
1 |
0.0009 |
| 299 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 300 |
PLEURAL EFFUSION |
53 |
0.0009 |
| 301 |
DRUG EXPOSURE DURING PREGNANCY |
29 |
0.0009 |
| 302 |
GLOMERULONEPHRITIS MEMBRANOUS |
1 |
0.0009 |
| 303 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
2 |
0.0008 |
| 304 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 305 |
ENDOMETRIOSIS |
4 |
0.0008 |
| 306 |
EMBOLISM ARTERIAL |
1 |
0.0008 |
| 307 |
STILLBIRTH |
4 |
0.0008 |
| 308 |
FOETAL GROWTH RESTRICTION |
5 |
0.0008 |
| 309 |
INTRADUCTAL PROLIFERATIVE BREAST LESION |
1 |
0.0008 |
| 310 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 311 |
RETINAL ARTERY OCCLUSION |
2 |
0.0008 |
| 312 |
GASTRIC ULCER PERFORATION |
1 |
0.0008 |
| 313 |
DERMATOMYOSITIS |
2 |
0.0008 |
| 314 |
WEIGHT LOSS POOR |
4 |
0.0008 |
| 315 |
PRODUCT COLOUR ISSUE |
4 |
0.0008 |
| 316 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 317 |
FOETAL DEATH |
4 |
0.0008 |
| 318 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 319 |
EXPOSURE VIA FATHER |
1 |
0.0008 |
| 320 |
EXPOSURE VIA BREAST MILK |
3 |
0.0008 |
| 321 |
PREGNANCY |
15 |
0.0007 |
| 322 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
3 |
0.0007 |
| 323 |
LARGE INTESTINAL ULCER |
2 |
0.0007 |
| 324 |
NORMAL NEWBORN |
4 |
0.0007 |
| 325 |
HYDROCEPHALUS |
4 |
0.0007 |
| 326 |
EFFUSION |
1 |
0.0007 |
| 327 |
DEMYELINATION |
3 |
0.0007 |
| 328 |
DEATH NEONATAL |
1 |
0.0007 |
| 329 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 330 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 331 |
PRODUCT QUALITY ISSUE |
96 |
0.0007 |
| 332 |
UTERINE HAEMORRHAGE |
3 |
0.0007 |
| 333 |
INTENSIVE CARE |
1 |
0.0007 |
| 334 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
1 |
0.0007 |
| 335 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 336 |
PULMONARY PAIN |
2 |
0.0007 |
| 337 |
MELANOCYTIC NAEVUS |
3 |
0.0007 |
| 338 |
UTERINE LEIOMYOMA |
5 |
0.0007 |
| 339 |
BLOOD PARATHYROID HORMONE DECREASED |
1 |
0.0007 |
| 340 |
AXILLARY PAIN |
1 |
0.0007 |
| 341 |
ILEUS PARALYTIC |
3 |
0.0007 |
| 342 |
MATERNAL EXPOSURE DURING PREGNANCY |
59 |
0.0007 |
| 343 |
PRODUCT PHYSICAL ISSUE |
13 |
0.0006 |
| 344 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
0.0006 |
| 345 |
HYPERTHYROIDISM |
9 |
0.0006 |
| 346 |
LEUKOCYTOCLASTIC VASCULITIS |
1 |
0.0006 |
| 347 |
PRODUCT FORMULATION ISSUE |
4 |
0.0006 |
| 348 |
GASTRIC DILATATION |
1 |
0.0006 |
| 349 |
BK VIRUS INFECTION |
2 |
0.0006 |
| 350 |
VULVOVAGINAL PRURITUS |
3 |
0.0006 |
| 351 |
LOWER RESPIRATORY TRACT CONGESTION |
1 |
0.0006 |
| 352 |
SUDDEN CARDIAC DEATH |
2 |
0.0006 |
| 353 |
NEEDLE ISSUE |
17 |
0.0006 |
| 354 |
CEREBRAL ISCHAEMIA |
3 |
0.0006 |
| 355 |
VIITH NERVE PARALYSIS |
2 |
0.0006 |
| 356 |
HYPOPITUITARISM |
1 |
0.0006 |
| 357 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 358 |
FOOD INTERACTION |
1 |
0.0006 |
| 359 |
PREMATURE BABY |
17 |
0.0006 |
| 360 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 361 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 362 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 363 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 364 |
DYSENTERY |
1 |
0.0005 |
| 365 |
RETINOPATHY |
2 |
0.0005 |
| 366 |
INCORRECT PRODUCT STORAGE |
7 |
0.0005 |
| 367 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 368 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 369 |
PROSTATOMEGALY |
2 |
0.0005 |
| 370 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 371 |
DIPLEGIA |
1 |
0.0005 |
| 372 |
EMPYEMA |
1 |
0.0005 |
| 373 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 374 |
VAGINAL DISCHARGE |
5 |
0.0005 |
| 375 |
GOITRE |
2 |
0.0005 |
| 376 |
ABNORMAL FAECES |
4 |
0.0005 |
| 377 |
ARTHRITIS BACTERIAL |
2 |
0.0005 |
| 378 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 379 |
THYROID FUNCTION TEST ABNORMAL |
2 |
0.0005 |
| 380 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 381 |
PRODUCT DOSE OMISSION ISSUE |
139 |
0.0005 |
| 382 |
INJECTION SITE IRRITATION |
6 |
0.0005 |
| 383 |
HEPATIC CYTOLYSIS |
6 |
0.0005 |
| 384 |
POOR PERIPHERAL CIRCULATION |
2 |
0.0005 |
| 385 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 386 |
BLOOD TESTOSTERONE INCREASED |
1 |
0.0005 |
| 387 |
POOR QUALITY DRUG ADMINISTERED |
3 |
0.0005 |
| 388 |
VAGINAL HAEMORRHAGE |
20 |
0.0005 |
| 389 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 390 |
CYTOMEGALOVIRUS VIRAEMIA |
2 |
0.0004 |
| 391 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 392 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 393 |
LIP DRY |
4 |
0.0004 |
| 394 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 395 |
PRODUCT PREPARATION ERROR |
9 |
0.0004 |
| 396 |
NEPHROTIC SYNDROME |
3 |
0.0004 |
| 397 |
HUNGER |
6 |
0.0004 |
| 398 |
INJECTION SITE REACTION |
29 |
0.0004 |
| 399 |
METASTASIS |
3 |
0.0004 |
| 400 |
GESTATIONAL DIABETES |
2 |
0.0004 |
| 401 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 402 |
CIRCULATORY COLLAPSE |
7 |
0.0004 |
| 403 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 404 |
INJECTION SITE URTICARIA |
10 |
0.0004 |
| 405 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 406 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 407 |
BREAST TENDERNESS |
3 |
0.0004 |
| 408 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0004 |
| 409 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 410 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 411 |
INJURY ASSOCIATED WITH DEVICE |
8 |
0.0004 |
| 412 |
INCREASED BRONCHIAL SECRETION |
1 |
0.0004 |
| 413 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 414 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 415 |
CONGENITAL ANOMALY |
3 |
0.0004 |
| 416 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 417 |
ABDOMINAL PAIN |
88 |
0.0004 |
| 418 |
PREMATURE DELIVERY |
6 |
0.0004 |
| 419 |
ABDOMINAL MASS |
1 |
0.0004 |
| 420 |
INJECTION SITE PRURITUS |
25 |
0.0004 |
| 421 |
RHINITIS |
3 |
0.0004 |
| 422 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 423 |
PRODUCT STORAGE ERROR |
32 |
0.0004 |
| 424 |
AUTISM SPECTRUM DISORDER |
2 |
0.0004 |
| 425 |
PRODUCT USE IN UNAPPROVED INDICATION |
90 |
0.0004 |
| 426 |
ATRIAL SEPTAL DEFECT |
3 |
0.0004 |
| 427 |
MACULAR OEDEMA |
2 |
0.0004 |
| 428 |
VENTRICULAR SEPTAL DEFECT |
2 |
0.0003 |
| 429 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 430 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 431 |
HAEMOTHORAX |
1 |
0.0003 |
| 432 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 433 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 434 |
HYPOVOLAEMIA |
2 |
0.0003 |
| 435 |
BRAIN HERNIATION |
1 |
0.0003 |
| 436 |
DEVELOPMENTAL DELAY |
3 |
0.0003 |
| 437 |
KERATITIS |
1 |
0.0003 |
| 438 |
DYSCHEZIA |
1 |
0.0003 |
| 439 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 440 |
MUSCULOSKELETAL CHEST PAIN |
5 |
0.0003 |
| 441 |
APPENDICITIS |
3 |
0.0003 |
| 442 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 443 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 444 |
CARDIOVASCULAR DISORDER |
8 |
0.0003 |
| 445 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 446 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 447 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 448 |
FOETAL EXPOSURE DURING PREGNANCY |
25 |
0.0003 |
| 449 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 450 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 451 |
ADVERSE REACTION |
4 |
0.0003 |
| 452 |
SPINAL FRACTURE |
6 |
0.0003 |
| 453 |
INJECTION SITE MASS |
11 |
0.0003 |
| 454 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 455 |
METASTASES TO LYMPH NODES |
2 |
0.0003 |
| 456 |
HEPATIC CYST |
1 |
0.0003 |
| 457 |
INJECTION SITE RASH |
9 |
0.0003 |
| 458 |
METRORRHAGIA |
5 |
0.0003 |
| 459 |
DYSPNOEA EXERTIONAL |
11 |
0.0003 |
| 460 |
PERITONITIS |
6 |
0.0003 |
| 461 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 462 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 463 |
PETECHIAE |
3 |
0.0003 |
| 464 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 465 |
HANGOVER |
1 |
0.0003 |
| 466 |
COLD SWEAT |
5 |
0.0003 |
| 467 |
THERMAL BURN |
2 |
0.0003 |
| 468 |
EXPOSURE VIA SKIN CONTACT |
7 |
0.0003 |
| 469 |
DRUG EFFECT LESS THAN EXPECTED |
4 |
0.0003 |
| 470 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 471 |
INJECTION SITE PAIN |
81 |
0.0003 |
| 472 |
FACE INJURY |
1 |
0.0003 |
| 473 |
EXPOSURE DURING PREGNANCY |
16 |
0.0003 |
| 474 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 475 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 476 |
HAEMATOCRIT DECREASED |
5 |
0.0003 |
| 477 |
PRODUCT PRESCRIBING ERROR |
6 |
0.0003 |
| 478 |
RENAL CYST |
2 |
0.0003 |
| 479 |
MOOD SWINGS |
8 |
0.0003 |
| 480 |
HYPERPHAGIA |
1 |
0.0003 |
| 481 |
CANDIDIASIS |
1 |
0.0002 |
| 482 |
BLEPHARITIS |
1 |
0.0002 |
| 483 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 484 |
ENURESIS |
1 |
0.0002 |
| 485 |
FIBROMYALGIA |
6 |
0.0002 |
| 486 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 487 |
INJECTION SITE WARMTH |
5 |
0.0002 |
| 488 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 489 |
MENSTRUAL DISORDER |
2 |
0.0002 |
| 490 |
HEMIPLEGIA |
2 |
0.0002 |
| 491 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 492 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 493 |
INTESTINAL STENOSIS |
1 |
0.0002 |
| 494 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 495 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 496 |
POOR QUALITY SLEEP |
5 |
0.0002 |
| 497 |
CHAPPED LIPS |
1 |
0.0002 |
| 498 |
HYPERKALAEMIA |
8 |
0.0002 |
| 499 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 500 |
PRODUCT COMMUNICATION ISSUE |
2 |
0.0002 |
| 501 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 502 |
INJECTION SITE ERYTHEMA |
28 |
0.0002 |
| 503 |
HOT FLUSH |
17 |
0.0002 |
| 504 |
HAEMOLYTIC ANAEMIA |
2 |
0.0002 |
| 505 |
LOSS OF LIBIDO |
2 |
0.0002 |
| 506 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 507 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 508 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 509 |
CENTRAL NERVOUS SYSTEM LESION |
3 |
0.0002 |
| 510 |
DYSPAREUNIA |
1 |
0.0002 |
| 511 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 512 |
ERYTHEMA MULTIFORME |
2 |
0.0002 |
| 513 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 514 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 515 |
SYNCOPE |
21 |
0.0002 |
| 516 |
ATELECTASIS |
2 |
0.0002 |
| 517 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 518 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0002 |
| 519 |
CEREBRAL INFARCTION |
5 |
0.0002 |
| 520 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 521 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 522 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 523 |
INJECTION SITE BRUISING |
16 |
0.0002 |
| 524 |
POOR QUALITY DEVICE USED |
2 |
0.0002 |
| 525 |
OSTEOPENIA |
3 |
0.0002 |
| 526 |
SLUGGISHNESS |
2 |
0.0002 |
| 527 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 528 |
HYPONATRAEMIA |
11 |
0.0002 |
| 529 |
EAR DISCOMFORT |
2 |
0.0002 |
| 530 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 531 |
THYROID DISORDER |
3 |
0.0002 |
| 532 |
EMOTIONAL DISORDER |
6 |
0.0002 |
| 533 |
CACHEXIA |
1 |
0.0002 |
| 534 |
DRUG DOSE OMISSION |
32 |
0.0002 |
| 535 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 536 |
CATATONIA |
1 |
0.0002 |
| 537 |
PRODUCT USE COMPLAINT |
3 |
0.0002 |
| 538 |
RENAL PAIN |
2 |
0.0002 |
| 539 |
BREAST PAIN |
2 |
0.0002 |
| 540 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 541 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 542 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 543 |
ABDOMINAL DISCOMFORT |
31 |
0.0002 |
| 544 |
MENSTRUATION DELAYED |
2 |
0.0002 |
| 545 |
INCORRECT DOSE ADMINISTERED |
42 |
0.0002 |
| 546 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 547 |
INJECTION SITE SWELLING |
14 |
0.0002 |
| 548 |
MANIA |
3 |
0.0002 |
| 549 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 550 |
INJECTION SITE NODULE |
2 |
0.0002 |
| 551 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 552 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 553 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 554 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 555 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 556 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 557 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 558 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 559 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 560 |
METASTASES TO LUNG |
2 |
0.0002 |
| 561 |
HYPERVENTILATION |
1 |
0.0002 |
| 562 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 563 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 564 |
ENERGY INCREASED |
1 |
0.0002 |
| 565 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 566 |
PULMONARY EMBOLISM |
16 |
0.0002 |
| 567 |
ISCHAEMIC STROKE |
3 |
0.0002 |
| 568 |
THIRST |
3 |
0.0002 |
| 569 |
CHOLECYSTITIS |
2 |
0.0002 |
| 570 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 571 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 572 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 573 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 574 |
INGUINAL HERNIA |
1 |
0.0002 |
| 575 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
9 |
0.0002 |
| 576 |
PALPITATIONS |
19 |
0.0002 |
| 577 |
CYST |
2 |
0.0002 |
| 578 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 579 |
BLEPHAROSPASM |
1 |
0.0002 |
| 580 |
HYPOTHYROIDISM |
5 |
0.0002 |
| 581 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
0.0002 |
| 582 |
CHEST DISCOMFORT |
16 |
0.0002 |
| 583 |
CHOLESTASIS |
3 |
0.0002 |
| 584 |
PRESCRIBED OVERDOSE |
3 |
0.0002 |
| 585 |
HYPERPROLACTINAEMIA |
1 |
0.0002 |
| 586 |
HERPES SIMPLEX |
1 |
0.0002 |
| 587 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 588 |
CHOLELITHIASIS |
5 |
0.0002 |
| 589 |
ANKYLOSING SPONDYLITIS |
2 |
0.0002 |
| 590 |
PANCREATITIS |
8 |
0.0002 |
| 591 |
DYSMENORRHOEA |
2 |
0.0002 |
| 592 |
INTENTIONAL PRODUCT MISUSE |
13 |
0.0001 |
| 593 |
TACHYPNOEA |
2 |
0.0001 |
| 594 |
PALLOR |
4 |
0.0001 |
| 595 |
HEADACHE |
92 |
0.0001 |
| 596 |
MOOD ALTERED |
4 |
0.0001 |
| 597 |
JOINT EFFUSION |
1 |
0.0001 |
| 598 |
DRUG INTERACTION |
23 |
0.0001 |
| 599 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 600 |
ABNORMAL DREAMS |
4 |
0.0001 |
| 601 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 602 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 603 |
EXTRASYSTOLES |
1 |
0.0001 |
| 604 |
OSTEOARTHRITIS |
6 |
0.0001 |
| 605 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 606 |
FEAR OF INJECTION |
1 |
0.0001 |
| 607 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
5 |
0.0001 |
| 608 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 609 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
28 |
0.0001 |
| 610 |
FLUID OVERLOAD |
2 |
0.0001 |
| 611 |
APATHY |
2 |
0.0001 |
| 612 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 613 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 614 |
CONTUSION |
13 |
0.0001 |
| 615 |
WEIGHT INCREASED |
30 |
0.0001 |
| 616 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 617 |
IRRITABILITY |
8 |
0.0001 |
| 618 |
DERMATITIS ATOPIC |
7 |
0.0001 |
| 619 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 620 |
HYPERTHERMIA |
1 |
0.0001 |
| 621 |
LIPASE INCREASED |
1 |
0.0001 |
| 622 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 623 |
DYSPNOEA |
73 |
0.0001 |
| 624 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 625 |
APNOEA |
1 |
0.0001 |
| 626 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 627 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 628 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 629 |
NAUSEA |
100 |
0.0001 |
| 630 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 631 |
BLOOD DISORDER |
1 |
0.0001 |
| 632 |
NIGHT SWEATS |
4 |
0.0001 |
| 633 |
UNDERDOSE |
9 |
0.0001 |
| 634 |
LIVER INJURY |
3 |
0.0001 |
| 635 |
METASTASES TO BONE |
2 |
0.0001 |
| 636 |
LETHARGY |
7 |
0.0001 |
| 637 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 638 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 639 |
EMBOLISM |
1 |
0.0001 |
| 640 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 641 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 642 |
COAGULOPATHY |
2 |
0.0001 |
| 643 |
URTICARIA |
20 |
0.0001 |
| 644 |
HAEMODIALYSIS |
1 |
0.0001 |
| 645 |
HEMIPARESIS |
2 |
0.0001 |
| 646 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 647 |
PRODUCT USE ISSUE |
22 |
0.0001 |
| 648 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 649 |
HAEMATURIA |
4 |
0.0001 |
| 650 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 651 |
DIPLOPIA |
3 |
0.0001 |
| 652 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 653 |
MUSCLE SPASMS |
21 |
0.0001 |
| 654 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 655 |
AMENORRHOEA |
2 |
0.0001 |
| 656 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 657 |
DEPRESSED MOOD |
6 |
0.0001 |
| 658 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 659 |
HAEMARTHROSIS |
1 |
0.0001 |
| 660 |
HIDRADENITIS |
1 |
0.0001 |
| 661 |
OFF LABEL USE |
96 |
0.0001 |
| 662 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 663 |
ADVERSE EVENT |
10 |
0.0001 |
| 664 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 665 |
FLANK PAIN |
1 |
0.0001 |
| 666 |
LACERATION |
1 |
0.0001 |
| 667 |
CONDITION AGGRAVATED |
32 |
0.0001 |
| 668 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 669 |
ORAL HERPES |
2 |
0.0001 |
| 670 |
VOMITING |
48 |
0.0001 |
| 671 |
COELIAC DISEASE |
1 |
0.0001 |
| 672 |
MENORRHAGIA |
2 |
0.0001 |
| 673 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 674 |
BURNING SENSATION |
7 |
0.0001 |
| 675 |
SLEEP DISORDER |
7 |
0.0001 |
| 676 |
DRY THROAT |
1 |
0.0001 |
| 677 |
SUICIDAL IDEATION |
9 |
0.0001 |
| 678 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 679 |
MOBILITY DECREASED |
7 |
0.0001 |
| 680 |
ACCIDENTAL EXPOSURE TO PRODUCT |
10 |
0.0001 |
| 681 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 682 |
DIZZINESS |
48 |
0.0001 |
| 683 |
HAEMORRHAGE |
10 |
0.0001 |
| 684 |
DRUG INEFFECTIVE |
125 |
0.0001 |
| 685 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 686 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 687 |
RETCHING |
2 |
0.0001 |
| 688 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 689 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 690 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 691 |
FATIGUE |
72 |
0.0001 |
| 692 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 693 |
OEDEMA |
5 |
0.0001 |
| 694 |
BACK INJURY |
1 |
0.0001 |
| 695 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 696 |
FEELING ABNORMAL |
22 |
0.0001 |
| 697 |
CONSTIPATION |
20 |
0.0001 |
| 698 |
INTENTIONAL PRODUCT USE ISSUE |
8 |
0.0001 |
| 699 |
EYE DISORDER |
3 |
0.0001 |
| 700 |
ASTHENIA |
34 |
0.0001 |
| 701 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 702 |
URINARY RETENTION |
3 |
0.0001 |
| 703 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 704 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 705 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 706 |
NECK PAIN |
5 |
0.0001 |
| 707 |
MALNUTRITION |
1 |
0.0001 |
| 708 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 709 |
FLATULENCE |
5 |
0.0001 |
| 710 |
HEPATIC ENZYME INCREASED |
6 |
0.0001 |
| 711 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 712 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 713 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 714 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 715 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 716 |
EYELID OEDEMA |
1 |
0.0001 |
| 717 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 718 |
SWELLING |
8 |
0.0001 |
| 719 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 720 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 721 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 722 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 723 |
BURSITIS |
1 |
0.0001 |
| 724 |
PRESYNCOPE |
2 |
0.0001 |
| 725 |
RESTLESSNESS |
3 |
0.0001 |
| 726 |
CYTOPENIA |
1 |
0.0001 |
| 727 |
CARDIOMEGALY |
1 |
0.0001 |
| 728 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 729 |
BRAIN OEDEMA |
1 |
0.0001 |
| 730 |
HYPOPHAGIA |
2 |
0.0001 |
| 731 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 732 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 733 |
HIATUS HERNIA |
1 |
0.0001 |
| 734 |
RASH GENERALISED |
2 |
0.0001 |
| 735 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 736 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 737 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 738 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 739 |
PAIN |
46 |
0.0001 |
| 740 |
GASTROOESOPHAGEAL REFLUX DISEASE |
6 |
0.0001 |
| 741 |
SOMNOLENCE |
15 |
0.0001 |
| 742 |
LIMB INJURY |
2 |
0.0001 |
| 743 |
POLLAKIURIA |
3 |
0.0001 |
| 744 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 745 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 746 |
APHONIA |
1 |
0.0001 |
| 747 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 748 |
RASH |
31 |
0.0001 |
| 749 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 750 |
HEART RATE INCREASED |
7 |
0.0001 |
| 751 |
PAIN IN JAW |
2 |
0.0001 |
| 752 |
HERPES ZOSTER |
4 |
0.0001 |
| 753 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 754 |
HYPOKINESIA |
1 |
0.0001 |
| 755 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 756 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 757 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 758 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 759 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 760 |
APHASIA |
2 |
0.0001 |
| 761 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 762 |
VERTIGO |
4 |
0.0001 |
| 763 |
DISCOMFORT |
4 |
0.0001 |
| 764 |
SKIN IRRITATION |
3 |
0.0001 |
| 765 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 766 |
PRURITUS |
25 |
0.0001 |
| 767 |
HYPOKALAEMIA |
3 |
0.0001 |
| 768 |
GYNAECOMASTIA |
2 |
0.0001 |
| 769 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 770 |
MENINGIOMA |
1 |
0.0001 |
| 771 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 772 |
BRAIN FOG |
1 |
0.0001 |
| 773 |
ANXIETY |
18 |
0.0001 |
| 774 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 775 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 776 |
COMA |
3 |
0.0001 |
| 777 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 778 |
MIGRAINE |
6 |
0.0001 |
| 779 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 780 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 781 |
MALAISE |
27 |
0.0001 |
| 782 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
11 |
0.0001 |
| 783 |
WEIGHT DECREASED |
17 |
0.0001 |
| 784 |
FUNGAL INFECTION |
2 |
0.0001 |
| 785 |
DRY SKIN |
8 |
0.0001 |
| 786 |
GAIT INABILITY |
2 |
0.0001 |
| 787 |
FLUID RETENTION |
3 |
0.0001 |
| 788 |
ECZEMA |
3 |
0.0001 |
| 789 |
LOCAL SWELLING |
1 |
0.0001 |
| 790 |
SPEECH DISORDER |
3 |
0.0001 |
| 791 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 792 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 793 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 794 |
DRUG ERUPTION |
1 |
0.0001 |
| 795 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 796 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 797 |
DRUG EFFECT DECREASED |
3 |
0.0001 |
| 798 |
COMPLICATION OF DEVICE REMOVAL |
1 |
0.0001 |
| 799 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 800 |
CRYING |
2 |
0.0001 |
| 801 |
PANIC ATTACK |
2 |
0.0001 |
| 802 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 803 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 804 |
HYPERHIDROSIS |
7 |
0.0001 |
| 805 |
DYSURIA |
2 |
0.0001 |
| 806 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 807 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 808 |
MEDICATION ERROR |
3 |
0.0001 |
| 809 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 810 |
ERYTHEMA |
11 |
0.0001 |
| 811 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 812 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 813 |
FEELING JITTERY |
1 |
0.0001 |
| 814 |
INCREASED APPETITE |
1 |
0.0001 |
| 815 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 816 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 817 |
SEIZURE |
6 |
0.0001 |
| 818 |
GLAUCOMA |
1 |
0.0001 |
| 819 |
ERUCTATION |
1 |
0.0001 |
| 820 |
DECREASED APPETITE |
12 |
0.0001 |
| 821 |
BONE PAIN |
3 |
0.0001 |
| 822 |
CHILLS |
6 |
0.0001 |
| 823 |
SURGERY |
3 |
0.0001 |
| 824 |
NASAL CONGESTION |
3 |
0.0001 |
| 825 |
DYSPEPSIA |
5 |
0.0001 |
| 826 |
DISORIENTATION |
2 |
0.0001 |
| 827 |
THROMBOSIS |
4 |
0.0000 |
| 828 |
DIARRHOEA |
32 |
0.0000 |
| 829 |
SUICIDE ATTEMPT |
3 |
0.0000 |
| 830 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 831 |
FEEDING DISORDER |
1 |
0.0000 |
| 832 |
FLUSHING |
5 |
0.0000 |
| 833 |
FEELING HOT |
3 |
0.0000 |
| 834 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 835 |
OSTEOPOROSIS |
2 |
0.0000 |
| 836 |
CHEST PAIN |
9 |
0.0000 |
| 837 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 838 |
DEPRESSION |
11 |
0.0000 |
| 839 |
TREATMENT FAILURE |
4 |
0.0000 |
| 840 |
DERMATITIS |
1 |
0.0000 |
| 841 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 842 |
EATING DISORDER |
1 |
0.0000 |
| 843 |
JOINT INJURY |
1 |
0.0000 |
| 844 |
HYPOAESTHESIA |
7 |
0.0000 |
| 845 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 846 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 847 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 848 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 849 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 850 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 851 |
TACHYCARDIA |
4 |
0.0000 |
| 852 |
DEHYDRATION |
6 |
0.0000 |
| 853 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 854 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 855 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 856 |
TINNITUS |
2 |
0.0000 |
| 857 |
PYREXIA |
15 |
0.0000 |
| 858 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 859 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 860 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
2 |
0.0000 |
| 861 |
HYPERTENSION |
9 |
0.0000 |
| 862 |
ARRHYTHMIA |
2 |
0.0000 |
| 863 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 864 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 865 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 866 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 867 |
MYALGIA |
7 |
0.0000 |
| 868 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 869 |
LUNG DISORDER |
2 |
0.0000 |
| 870 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 871 |
LEUKOPENIA |
2 |
0.0000 |
| 872 |
ACNE |
3 |
0.0000 |
| 873 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 874 |
HAEMATEMESIS |
1 |
0.0000 |
| 875 |
DRUG RESISTANCE |
1 |
0.0000 |
| 876 |
INFLAMMATION |
2 |
0.0000 |
| 877 |
HAEMATOMA |
1 |
0.0000 |
| 878 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 879 |
JOINT STIFFNESS |
1 |
0.0000 |
| 880 |
ANHEDONIA |
1 |
0.0000 |
| 881 |
GASTRITIS |
1 |
0.0000 |
| 882 |
INSOMNIA |
10 |
0.0000 |
| 883 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 884 |
FEAR |
1 |
0.0000 |
| 885 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 886 |
OVERDOSE |
8 |
0.0000 |
| 887 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 888 |
CARDIAC ARREST |
3 |
0.0000 |
| 889 |
DIVERTICULITIS |
1 |
0.0000 |
| 890 |
FEELING COLD |
1 |
0.0000 |
| 891 |
COUGH |
10 |
0.0000 |
| 892 |
ASTHMA |
4 |
0.0000 |
| 893 |
MUSCULAR WEAKNESS |
4 |
0.0000 |
| 894 |
HYPERSOMNIA |
1 |
0.0000 |
| 895 |
BACK PAIN |
8 |
0.0000 |
| 896 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 897 |
DYSSTASIA |
1 |
0.0000 |
| 898 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 899 |
COVID-19 |
6 |
0.0000 |
| 900 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 901 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 902 |
BREAST CANCER |
3 |
0.0000 |
| 903 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 904 |
HEAD INJURY |
1 |
0.0000 |
| 905 |
CYSTITIS |
1 |
0.0000 |
| 906 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 907 |
DEVICE EXPULSION |
2 |
0.0000 |
| 908 |
ALOPECIA |
6 |
0.0000 |
| 909 |
DEVICE DIFFICULT TO USE |
2 |
0.0000 |
| 910 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 911 |
ANGER |
1 |
0.0000 |
| 912 |
CEREBROVASCULAR ACCIDENT |
5 |
0.0000 |
| 913 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 914 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 915 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 916 |
ILLNESS |
3 |
0.0000 |
| 917 |
ARTHRALGIA |
12 |
0.0000 |
| 918 |
DELIRIUM |
1 |
0.0000 |
| 919 |
DEVICE USE ERROR |
1 |
0.0000 |
| 920 |
INJURY |
2 |
0.0000 |
| 921 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 922 |
AGITATION |
2 |
0.0000 |
| 923 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 924 |
DYSGEUSIA |
2 |
0.0000 |
| 925 |
INFLUENZA |
3 |
0.0000 |
| 926 |
DYSARTHRIA |
1 |
0.0000 |
| 927 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 928 |
COLITIS |
1 |
0.0000 |
| 929 |
ANAEMIA |
5 |
0.0000 |
| 930 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 931 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 932 |
JOINT SWELLING |
3 |
0.0000 |
| 933 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 934 |
BLINDNESS |
1 |
0.0000 |
| 935 |
TREMOR |
4 |
0.0000 |
| 936 |
HYPOACUSIS |
1 |
0.0000 |
| 937 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 938 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 939 |
MENTAL DISORDER |
1 |
0.0000 |
| 940 |
ANGIOEDEMA |
1 |
0.0000 |
| 941 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 942 |
VISION BLURRED |
3 |
0.0000 |
| 943 |
PNEUMONIA |
7 |
0.0000 |
| 944 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 945 |
FALL |
7 |
0.0000 |
| 946 |
INFECTION |
3 |
0.0000 |
| 947 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 948 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 949 |
DRY EYE |
1 |
0.0000 |
| 950 |
AGGRESSION |
1 |
0.0000 |
| 951 |
CELLULITIS |
1 |
0.0000 |
| 952 |
PARAESTHESIA |
3 |
0.0000 |
| 953 |
BRADYCARDIA |
1 |
0.0000 |
| 954 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 955 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 956 |
ARTHROPATHY |
1 |
0.0000 |
| 957 |
SEPSIS |
2 |
0.0000 |
| 958 |
BLISTER |
1 |
0.0000 |
| 959 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 960 |
CONVULSION |
1 |
0.0000 |
| 961 |
EYE IRRITATION |
1 |
0.0000 |
| 962 |
DYSPHONIA |
1 |
0.0000 |
| 963 |
CATARACT |
1 |
0.0000 |
| 964 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 965 |
AMNESIA |
1 |
0.0000 |
| 966 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 967 |
PSORIASIS |
2 |
0.0000 |
| 968 |
RENAL FAILURE |
2 |
0.0000 |
| 969 |
HYPOTENSION |
3 |
0.0000 |
| 970 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 971 |
BRONCHITIS |
1 |
0.0000 |
| 972 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 973 |
CARDIAC FAILURE |
1 |
0.0000 |
| 974 |
DRY MOUTH |
1 |
0.0000 |
| 975 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 976 |
DRUG ABUSE |
1 |
0.0000 |
| 977 |
BALANCE DISORDER |
1 |
0.0000 |
| 978 |
DEVICE ISSUE |
1 |
0.0000 |
| 979 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 980 |
CARDIAC DISORDER |
1 |
0.0000 |
| 981 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 982 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 983 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 984 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 985 |
HOSPITALISATION |
1 |
0.0000 |
| 986 |
DEATH |
4 |
0.0000 |